Examining Provincial HPV Vaccination Schemes in Canada: Should We Standardise the Grade of Vaccination or the Number of Doses?

Table 2

List of parameters and state variables.

Parameter	Description	Range	Sample value	Reference
	Unvaccinated children in grade	(State variable)
	Unvaccinated adult women	(State variable)
	Vaccinated children in grade	(State variable)
	Vaccinated adult women	(State variable)
	Uninfected adult women	(State variable)
	Infected adult women	(State variable)
	Uninfected men	(State variable)
	Infected men	(State variable)
,	Birth rate for women, men	50–100 people	100	[4]
	Mortality rate for children	1/50–1/90 year^−1	1/90	1/avg. time in compartment
	Leaving rate for adults	1/12–1/8 year^−1	1/10	1/avg. time in compartment
	Vaccine efficacy in female children	93.3–99.8% 2 doses	0.97	[3]
		93.3–99.8% 3 doses	0.99	[3]
	Vaccine efficacy in adult women	50.2–96.3% 2 doses	0.809	[3, 5, 21–24]
		71.1–87.7% 3 doses	0.841	[3, 5, 21–24]
, where	Proportion of children vaccinated within the corresponding grade	0–100%		[16, 17, 19, 20]
	Proportion of previously unvaccinated adult women vaccinated	0–100%		[16, 17, 19, 20]
	Transmission of infection of a woman by an infected man	0.01–2 year^−1	0.77	[2]
	Transmission of infection of a man by an infected woman	0.01–2 year^−1	0.77	[2]
	Proportion of infected girls at age 15 unvaccinated, vaccinated	0–30%	10%	[25]
	Probability of protection against all targeted types	0.3–1	0.44	[23]
	Recovery rate for unvaccinated women, vaccinated women, men	1/2–4/3 year^−1	2/3	[26, 27]
	Attenuation constant	0–0.3 year^−1		[4]
	Maximal possible rate of adult vaccination	0–0.2	0.1	[4]
	Rate at which unvaccinated women are vaccinated			[4]
	Waning rate	0.2–1 year^−1 2 doses	0.5	[28]
		0.1–0.5 year^−1 3 doses	0.333	[28]